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The functional expression of P2X receptors at the plasma membrane is dependent on
their trafficking along secretory and endocytic pathways. There are seven P2X receptor
subunits, and these differ in their subcellular distributions because they have very different
trafficking properties. Some are retained within the endoplasmic reticulum (ER), while
others are predominantly at the cell surface or within endosomes and lysosomes.
Changes in recruitment of receptors to and from the plasma membrane provides a way
of rapidly up- or down-regulating the cellular response to adenosine triphosphate (ATP).
An additional layer of regulation is the targeting of these receptors within the membranes
of each compartment, which affects their stability, function and the nature of the effector
proteins with which they form signaling complexes. The trafficking and targeting of P2X
receptors is regulated by their interactions with other proteins and with lipids and we
can expect this to vary in a cell-type specific manner and in response to changes in the
environment giving rise to differences in receptor activity and function.
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INTRODUCTION
P2X receptors open an integral ion channel at the plasma mem-
brane in response to binding extracellular adenosine triphosphate
(ATP). Some subtypes of P2X receptor are predominantly within
intracellular membranes, but there is no compelling evidence that
the receptors on intracellular membranes open in response to
ATP, at least in mammals. Nonetheless, this remains an intriguing
possibility, given that the distantly related P2X-like receptors in
Dictyostelium are located and function within contractile vacuoles
(Fountain et al., 2007; Ludlow et al., 2009; Sivaramakrishnan
and Fountain, 2012a,b; Baines et al., 2013). The best-established
role of the internal mammalian P2X receptors is, therefore, to
regulate the expression and activity of receptors at the cell surface.
Here we consider three related issues concerning the targeting
and trafficking of P2X receptors: first, primary location, and
the amino acid motifs which determine it; second, regulation
of mobility both within the plasma membrane and between the
plasma membrane and intracellular membranes; third, targeting
to lipid rafts and the effects of the lipid environment on receptor
signaling.
SUBCELLULAR LOCALIZATION OF P2X RECEPTORS
Trimeric P2X receptor complexes assemble and are core glycosy-
lated within the endoplasmic reticulum (ER) and then traffic via
the trans-Golgi network (TGN) to the plasma membrane.
They are subsequently internalized and either recycled back
to the surface or targeted to late endosomes and lysosomes. The
kinetics of these processes determines receptor distribution.
ER RESIDENT P2X RECEPTORS
P2X receptors are predominantly found within the ER, at the
plasma membrane or within late endosomes and lysosomes,
dependent upon the subtype (Figure 1). The only full-length
P2X receptor that is retained within the ER and is therefore
non-functional is P2X6 (Ormond et al., 2006). Imaging of
P2X6 receptors by atomic force microscopy indicates that
the subunits do not assemble to form stable homotrimeric
complexes, but they do form stable heterotrimers with either
P2X2 or P2X4 (Bobanovic et al., 2002; Barrera et al., 2005, 2007;
Ormond et al., 2006). The P2X2/6 and P2X4/6 receptors are
expressed as functional receptors at the plasma membrane and
have trafficking properties that resemble the P2X2 and P2X4
homomeric receptors respectively. In the category of ER resident
P2X receptors there is also the human P2X5 receptor. Although
the full-length P2X5 receptor traffics to the cell surface, the
predominant allele expressed in most humans gives rise to an
exon 10-deleted variant which is retained in the ER (Bo et al.,
2003; Kotnis et al., 2010; Compan et al., 2012).
PLASMA MEMBRANE P2X RECEPTORS
Two subtypes that traffic relatively slowly through the secretory
pathway and hence often appear to have a predominantly ER
distribution are P2X2 and P2X7 receptors. P2X2 receptors are sta-
bly expressed at the plasma membrane, but, when heterologously
expressed, they accumulate slowly at the cell surface. This slow
traffic might be important for facilitating interactions with other
proteins along the way (Bobanovic et al., 2002). For example, in
spinal cord neurons, intracellular P2X2 receptors interact with
GABAA receptors and co-traffic to the surface (Shrivastava et al.,
2011). Another protein that interacts with P2X2 receptors to
regulate its targeting to synapses is the beta-amyloid precursor
protein-binding protein Fe65 (Masin et al., 2006). There is also
the neuronal calcium sensor, visinin-like protein-1 (VILIP-1)
that interacts with P2X2 in a calcium-dependent manner (Chau-
mont et al., 2008). These interacting proteins affect the stability,
targeting and function of the receptors at the plasma membrane.
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FIGURE 1 | The subcellular distribution of P2X receptors. P2X receptor
subtypes differ in their trafficking properties and hence are localized to
different subcellular compartments. P2X6 receptors are retained within the
ER but can assemble with P2X4 and P2X6 subunits to form heterotrimers
that traffic to the cell surface. The predominant human allele of P2X5 lacks
exon 10 and is also retained in the ER. P2X2 and P2X7 receptors traffic
relatively slowly through the secretory pathway but are stably expressed at
the surface. P2X1 receptors are expressed at the cell surface but rapidly cycle
to and from recycling endosomes. P2X3 and P2X4 receptors are consitutively
internalized and delivered to late endosomes and lysosomes. Within the
lysosomes, P2X3 receptors are rapidly degraded but P2X4 receptors resist
degradation and can recycle back to the surface.
P2X7 receptor trafficking is dependent upon cell-type and
species. For example, in human monocytes and lymphocytes,
P2X7 receptors are predominantly intracellular, but upon dif-
ferentiation of monocytes to macrophages receptors locate to
the plasma membrane (Hickman et al., 1994; Gu et al., 2000;
Gudipaty et al., 2001). Native P2X7 receptors in rodent microglia
and macrophages are also predominantly at the plasma mem-
brane (Boumechache et al., 2009). What regulates the rate at
which P2X7 receptors traffic from the ER to the cell surface is
unknown, although mutagenesis analysis suggests that it involves
the cytoplasmic C-terminal domain of the receptor (Denlinger
et al., 2003; Smart et al., 2003).
P2X1 receptors are predominantly at the cell surface, and at
least one interacting protein has been identified, namely heat
shock protein 90, which further promotes their trafficking and
plasma membrane expression (Lalo et al., 2010, 2012). At the
plasma membrane, P2X1 receptors differ in trafficking behavior
from P2X2 receptors. P2X2 receptors are relatively stable and
show little constitutive internalization over a period of an hour
(Bobanovic et al., 2002). In contrast, measurements of P2X1
receptor mobility by fluorescence recovery after photobleaching
(FRAP) shows that receptors undergo considerable internaliza-
tion and recycling over a similar time period (Lalo et al., 2010).
Their surface localization indicates that recycling is rapid com-
pared to their rate of endocytosis and targeting to late endosomes.
ENDO-LYSOSOMAL P2X RECEPTORS
P2X3 and P2X4 receptors also undergo rapid constitutive inter-
nalization from the plasma membrane, but unlike P2X1 they
are predominantly localized to late endosomes and lysosomes
(Bobanovic et al., 2002; Qureshi et al., 2007; Vacca et al., 2009).
For P2X3 receptors this has been shown for heterologously
expressed receptors in HEK293 cells and also for native receptors
in dorsal root ganglion (DRG) neurons (Vacca et al., 2009). For
P2X4 receptors, their localization to endolysosomes has been
shown in immune and endothelial cells as well as for the het-
erologously expressed receptors in neurons (Bobanovic et al.,
2002; Royle et al., 2002; Qureshi et al., 2007; Toulme et al.,
2010). Constitutive endocytosis of P2X4 receptors is mediated
via a dynamin/clathrin-dependent process and can be inhib-
ited using dynasore (Bobanovic et al., 2002). Treatment with
dynasore rapidly up-regulates P2X4 receptors at the surface of
some but not all cells that express this receptor (Boumechache
et al., 2009). In cultured microglial cells, native P2X4 recep-
tors are rapidly up-regulated, indicating that they are contin-
ually cycling to and from the surface. In contrast, in bone
marrow derived macrophages, total P2X4 receptor expression
is high, but expression at the surface is very low and not
increased by 1 h incubation with dynasore, suggesting that
under basal conditions, receptors remain within endolysosomal
compartments.
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P2X3 receptors have a high rate of turnover, caused by rapid
endocytosis and targeting to lysosomes, where the receptor is
degraded (Vacca et al., 2009). In contrast, P2X4 receptors are sur-
prisingly stable: they are resistant to degradation in the lysosome
and they show little turnover over a period of 24 h (Qureshi et al.,
2007). Their resistance to degradation is dependent uponmultiple
N-linked glycans which decorate the loop between the first and
second transmembrane domains (TMD), which is predicted to
face towards the lumen of lysosomes. Glycosylation is thought to
play a similar role in protecting other lysosome-targeted proteins,
such as Lamp-1, from degradation (Kundra and Kornfeld, 1999).
P2XR MOTIFS THAT DETERMINE RECEPTOR TRAFFICKING
P2X receptors share a YXXXK in the C-terminus which regulates
surface expression (Chaumont et al., 2004). This motif is situated
eight residues downstream of TMD2, and in P2X7 after an addi-
tional 18 amino acid cysteine-rich region. For P2X2 receptors,
mutations around this motif reduce the stability of the receptor
at the plasma membrane and increase internalization. Mutations
within the motif similarly reduce the plasma membrane expres-
sion of other P2X receptor subtypes (Chaumont et al., 2004).
The P2X4 receptor has two tyrosine-based endocytic motifs
within the C-terminus and one di-leucine-like motif within the
N-terminus (Royle et al., 2002, 2005; Qureshi et al., 2007). Muta-
tions of Y378, which forms part of a non-canonical YXXGmotif,
substantially slow receptor endocytosis, suggesting that this is the
more accessible of the two tyrosine-based motifs (Royle et al.,
2002, 2005). These mutants still, however, show targeting to
lysosomes, but this is further inhibited by mutating the leucine
and isoleucine pair within the N-terminus.
Though the P2X3 receptor does not share any endocytic motifs
with P2X4, there is a di-leucine motif in its C-terminal tail and
also a consensus sequence for ubiquitination (DSGXS) that is
suggested to be involved in the endocytosis and rapid degradation
of the receptor (Vacca et al., 2009).
For P2X7 receptors, several mutations, deletions and naturally
occurring single nucleotide polymorphisms (SNPs) within the
long C-terminal tail have been shown to disrupt its normal traf-
ficking to the plasmamembrane. Attention has mostly focused on
the distal end of the C-terminus of P2X7 (573–590), where there is
a region with strong amino acid identity to the lipopolysaccharide
(LPS) binding region of the LPS binding protein (Denlinger et al.,
2001). Truncations and mutations within a region overlapping
this site (551–581) disrupt normal receptor trafficking in HEK293
cells (Smart et al., 2003). For example, the I568N SNP in human
P2X7 receptors disrupts normal trafficking and function (Wiley
et al., 2003), as does substitution of acidic residues for the
dibasic R578 and K579 (Denlinger et al., 2003). More recently
it was shown that mutations within this region also disrupt the
normal targeting of rat P2X7 receptors in polarized epithelial
cells (Bradley et al., 2010). Alanine substitutions at P582-Q587
switched receptor targeting from the basolateral to the apical
membrane but without disrupting plasma membrane expres-
sion or receptor function. Although site-directed mutagenesis
has revealed critical residues in P2X7 receptor trafficking, the
mechanism(s) underlying their involvement remains unknown.
REGULATION OF RECEPTOR TRAFFICKING AND MOBILITY
The activation of P2X receptors regulates their trafficking to and
from the plasma membrane and their mobility within the plasma
membrane in a calcium-dependent manner. Agonist-stimulated
P2X receptor internalization and recycling back to the plasma
membrane was first shown for P2X1 in rat vas deferens (Ennion
and Evans, 2001). A later study of P2X1 mobility in HEK293 cells
showed an increase in the rate of FRAP at the cell surface in the
presence of agonist, which was dependent upon a rise in calcium,
upon clathrin-mediated endocytosis and upon trafficking of vesi-
cles back to the surface (Lalo et al., 2010). P2X1 receptors rapidly
desensitize in the presence of agonist and inhibiting the inter-
nalization and recycling of receptors reduces the rate of recovery
from desensitization. The P2X3 receptor also rapidly desensitizes
and shows agonist-stimulated internalization (Vacca et al., 2009).
P2X4 receptors desensitize more slowly but inhibiting dynamin-
mediated endocytosis similarly slows the resensitization process
(Murrell-Lagnado, unpublished). Thus, receptor retrieval and
recycling appears to be important for maintaining the activity of
the surface receptors.
Enhanced translocation of intracellular receptors to the plasma
membrane has been shown to be a mechanism for up-regulating
receptor function, particularly for those receptors that are
predominantly intracellular. P2X4 receptors translocate from
endolysosomes back to the surface, whereas for P2X3 receptors it
is unclear whether up-regulation involves increased delivery from
the secretory or endocytic pathway. ATP produces a transient
increase in the number of P2X3 receptors at the surface causing
sensitization of the current to repetitive doses (Vacca et al., 2009).
Another example of increased trafficking of P2X3 receptors to the
plasma membrane is in trigeminal sensory neurons in response
to calcitonin gene-related peptide (CGRP; Fabbretti et al., 2006).
A 1 h incubation with CGRP increased both the amplitude of
P2X3 receptor currents and their rate of recovery from desensiti-
zation. For P2X4 receptors in macrophages, surface expression is
increased in response to stimuli that promote lysosome exocytosis
either by increasing cytosolic calcium or by alkalinization of the
lysosomes (Qureshi et al., 2007). In the cerebellar microglial cell
line, C8-B4, P2X4 receptor currents are negligible in resting cells,
but after activating cells with either LPS or fibronectin, receptors
translocate from lysosomes to the surface to enhance receptor-
mediated currents (Toulme et al., 2010). Anti-depressants, which
inhibit these currents, act by blocking this translocation process
rather than by directly inhibiting the opening of the channel pore
(Toulme et al., 2010). This mode of action could prove to be a
useful way of selectively targeting the different subtypes with new
therapeutics.
It is not only the retrieval and recycling of P2X receptors
that is sensitive to agonist stimulation: their mobility within
the lateral plane of the plasma membrane is promoted by the
binding of ATP triggering a local influx of calcium. P2X2 recep-
tor mobility was measured in hippocampal neurons by imaging
single molecules using a quantum dot-based approach, and a
similar approach was used with P2X4 receptors in microglia
(Richler et al., 2011; Toulme and Khakh, 2012). In both cases
two populations of receptor were observed, characterized as the
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mobile and the slowly mobile pool. Neither population correlated
with clusters of receptors or receptors localized in lipid rafts, so
the molecular basis for the different mobility is unclear. Both
populations showed increased mobility in response to ATP. For
P2X2 receptors, mobility was also increased by the co-expression
of VILIP-1 (Richler et al., 2011). The implications of this increased
lateral mobility for receptor signaling remains to be established.
TARGETING OF P2X RECEPTORS TO LIPID RAFTS
The plasma membrane is an extremely heterogeneous
environment and the trafficking and function of P2X receptors
are regulated by the proteins and lipids within their immediate
environment, with which they interact. Lipid rafts are commonly
defined as microdomains rich in cholesterol, sphingolipids and
saturated phospholipids, but there is heterogeneity amongst
these domains in terms of their protein and lipid composition
(Pike, 2004). While some proteins are targeted to rafts, others are
excluded, affecting the nature of the signaling complexes formed
and their stability within the membrane.
Lipid rafts are often identified biochemically by their low
buoyant density in a sucrose density gradient, their resistance to
solubilization in Triton-X 100 and the presence of proteinmarkers
such as caveolin-1 (Pike, 2004). Several of the P2X receptors
have been shown to associate with lipid rafts, but the degree
to which they distribute between the raft and non-raft fractions
depends upon the cells in which they are expressed and the
method used to prepare the rafts (Allsopp et al., 2010). P2X1-4
receptors expressed in HEK293 cells associate with rafts prepared
using a detergent-free method (Allsopp et al., 2010). When rafts
are instead prepared using Triton-X 100, the receptors shift to
non-raft fractions. P2X1 and P2X2 receptors are more resistant
to extraction from rafts by Triton-X 100 than are P2X3 and P2X4
receptors, suggesting that P2X1 and P2X2 interact more strongly
with the cholesterol enriched domains (Allsopp et al., 2010).
Native P2X receptors have also been shown to target to lipid
rafts. For P2X1 receptors, the distribution between raft and non-
raft fractions is dependent upon the cell type. For example, P2X1
receptors in smoothmuscle preparations from artery, vas deferens
and bladder are almost exclusively in rafts, whereas only 20% of
P2X1 receptors in platelets are in rafts (Vial and Evans, 2005; Vial
et al., 2006). Native P2X3 receptors in trigeminal sensory neurons
target to lipid rafts and, in a transgenic migraine mouse model,
up-regulation of these receptors correlates with an increase in
the abundance of lipid rafts and an increase in the fraction of
P2X3 receptors within rafts (Gnanasekaran et al., 2011). Thus
regulation of lipid rafts provides a mechanism for changing the
functional expression of these receptors. P2X7 receptors are also
found within rafts, both for heterologously-expressed receptors
in HEK293 cells and for native receptors in rat submandibular
glands, peritoneal macrophages and mouse lung alveolar cells
(Garcia-Marcos et al., 2006a,b; Barth et al., 2007, 2008; Gonnord
et al., 2009). Similar to P2X1-4, the association of P2X7 receptors
with rafts is dependent upon the method used for isolating them.
The receptors target to rafts prepared in detergent-free conditions,
but this is reduced by low concentrations of Triton-X-100. This
might reflect a weak association of P2X7 receptors with rafts or
a difference in the nature of the rafts isolated by these methods.
Rafts prepared in the absence of detergent retain a greater fraction
of inner leaflet-membrane lipids, in particular phosphatidylserine
(Pike et al., 2002) and this might be involved in stabilizing the
association with P2X7 receptors.
How P2X receptors target to rafts is unclear. For P2X7
receptors there is evidence to support the involvement of both
caveolin-1 and palmitoylation of the receptor within its cyto-
plasmic C-terminal domain (Barth et al., 2007, 2008; Gonnord
et al., 2009). P2X7 receptors palmitoylated with a radiolabeled
palmitate were detected exclusively in lipid rafts, while inhibiting
palmitoylation reduced receptor targeting to rafts. In mouse lung
alveolar epithelial cells, P2X7R and caveolin-1were detected in the
same native complexes and caveolin-1 co-immunoprecipitated
with P2X7 receptors (Weinhold et al., 2010). Also, epithelial cells
from the caveolin-1 knock-out mice showed reduced levels of
P2X7 immunostaining at the plasma membrane (Barth et al.,
2007, 2008). A role for caveolin-1 could explain cell-type depen-
dent differences in P2X7 receptor trafficking and function, such
as between fibroblasts, rich in caveolin-1, and some immune cells,
deficient in caveolin-1.
Depleting plasma membrane cholesterol with methyl-β-
cyclodextrin disrupts lipid rafts and alters the function of some
but not all of the P2X receptors. P2X1 receptor currents are
strongly inhibited by cholesterol depletion, whereas P2X2 recep-
tor currents are unchanged (Vial and Evans, 2005; Allsopp et al.,
2010). A region within the N-terminus of P2X1 proximal to
TMD1 was identified as an important determinant of cholesterol
sensitivity (Allsopp et al., 2010). Cholesterol sensitivity of P2X1
receptor currents was, however, abolished by a cytoskeletal stabi-
lizing agent, suggesting that lipid rafts regulate P2X1 by affecting
its interaction with the cytoskeleton (Lalo et al., 2011). P2X3
receptor currents in trigeminal sensory neurons were inhibited by
methyl-β-cyclodextrin treatment and desensitization was acceler-
ated (Gnanasekaran et al., 2011). P2X4 receptor currents in Thp-1
monocytes were similarly inhibited by depleting cholesterol (Li
and Fountain, 2012). The role of lipid rafts as regulators of
P2X7 receptor signaling is of particular interest because recep-
tor stimulation activates lipid-metabolizing enzymes, including
phospholipases and sphingomyelinases, that reside in lipid rafts
and whose substrates are also enriched in rafts. In cells from
rat submandibular glands, cholesterol depletion reduced ATP-
stimulated ceramide generation and phospholipase A2 activation,
consistent with the idea that targeting to rafts controls signaling
between the P2X7 receptor and its downstream effectors (Garcia-
Marcos et al., 2006a).
SUMMARY AND OUTLOOK
Formany of the P2X receptors we now have a basic understanding
of their trafficking properties and subcellular distributions, and in
some cases have identified regulators that can alter their traffick-
ing to and from the plasma membrane. For the P2X4 receptor, a
key unanswered question is why it stably resides within endolyso-
somes. Only for the type II alveolar cells has a role for P2X4 recep-
tors in the lamellar bodies, which resemble secretory lysosomes,
been demonstrated, and only upon their fusion with the plasma
membrane (Miklavc et al., 2011). It remains to be established
whether P2X4 receptors have additional roles within conventional
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or secretory lysosomes of other cells. P2X7 receptors are known to
be up-regulated in many different cell types under inflammatory
conditions, contributing to pathology (Lister et al., 2007). We
would like to understand what regulates the trafficking of these
receptors to and from the cell surface. For all of the P2X receptors
we would like to understand how the lipid environment controls
their function and stability. For P2X7 receptors this interaction
might also operate in the reverse direction: events downstream of
P2X7 receptor activation, including sphingomyelinase activation
and ceramide generation directly modify raft structure, thereby
providing the potential for cross-talk with other receptors that are
modulated by lipid rafts.
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